Participation in the National Campaign on Viral Hepatitis C and Non-Communicable Diseases among Administrative Workers of Ain Shams University, Egypt

Participation in the National Campaign on Viral Hepatitis C and Non-Communicable Diseases among Administrative Workers of Ain Shams University, Egypt

Nashwa I. Basyoni, Nourhan B. Abd-ElSamad, Mohamed F. Allam *, Samia I. El-Damaty

Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Egypt

 

World Journal of Medical Microbiology, 2023, 2, 584

 

DOI: 10.31586/wjmm.2023.584

 

Abstract:

Background: On the first of October 2018, the Egyptian Ministry of Health and Population (MOHP) launched an initiative; named “100 Million Healthy Lives”, for nationwide screening of hepatitis c virus (HCV) and non-communicable diseases (NCDs). Egypt has the highest prevalence of HCV infection in the world where about 10% of the Egyptian population is affected by the disease. NCDs are the leading cause of mortality in Egypt and account for about 84% of all deaths. This study was conducted to a) Estimate the prevalence of participation in the national campaign on viral hepatitis C and non-communicable diseases among administrative workers in Ain shams University (ASU), b) Estimate the self-reported satisfaction of these participants with the campaign. Subjects and Methods: A cross-sectional study was conducted on 400 administrative workers of ASU faculties between March and August 2019 in Cairo, Egypt. A multistage random sample was done. Results: The study showed that 96% of the study group participated in the campaign. “Evaluating health status” was considered the main reason for participation at 92%, followed by "desire to obtain follow-up card", at 36%. Non-participation rate was about 4% and the main cause of non-participation was “fear of needle prick". About 91% of the participants were satisfied with the provided services. Mass media played a major role in awareness about the campaign for 91% of participants. Conclusions: The majority of the study group participated and was satisfied with the campaign. Mass media played a major role in participant awareness of the campaign.

 

Keywords: Hepatitis C Virus, Non-Communicable Diseases, Participation, Satisfaction, Ain Shams University, Egypt.

 

World Journal of Medical Microbiology, 2023, 2, 584

https://www.scipublications.com/journal/index.php/wjmm/article/view/584

Post COVID-19 Symptoms?

Post COVID-19 Symptoms?

 

Nesma Nabil Ahmed Elgohary (1)

Mohamed Nazmy Farris (2)

Diaa Marzouk Abdel Hamid (1,3)

Mohamed Farouk Allam (1,3)

Salwa Mostafa Mohammad Abdel Rahman (1,4)

 

1. Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

2. Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

3. Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

4. Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

 

World Journal of Medical Microbiology, 2022, 1, 478

 

DOI: 10.31586/wjmm.2022.478

 

Abstract:

The SARS-COV-2 rapid spread caused an international public health emergency with unprecedented rates of morbidity and mortality. Post COVID-19 condition occurs as a spectrum of symptoms that present four or more weeks after acute infection with SARS-CoV-2. Most published data to date state 50-70% of hospitalized patients experienced at least one post-acute COVID-19 symptom up to 3 months after discharge. Commonly reported symptoms include; neurocognitive post COVID-19 (fatigue, dizziness, inattention, and brain fog), respiratory post-COVID (dyspnea, chest pain, and cough), and mental health related symptoms (insomnia, depression, and post-traumatic stress disorder). Additionally, gastro-intestinal post COVID-19 (diarrhea, vomiting, and abdominal pain) along with decline in quality of life and decreased ability to perform activities of daily living were reported. The response to post COVID-19 symptoms is still in its infancy despite being an emerging crisis as scientific evidence and robust data are nonetheless required for clear definition, identification of time frame, classification and management of the condition. New studies are needed to identify total and individual incidence/prevalence rates of different clinical presentations of post COVID-19 symptoms. These future studies will help us to o improve early recognition of long term symptoms after acute infection of COVID-19.

 

Keywords: Post COVID-19, COVID-19, Fatigue, Brain Fog, Dyspnea, Insomnia, Depression, Quality of Life.

 

World Journal of Medical Microbiology, 2022, 1, 478

 

https://www.scipublications.com/journal/index.php/wjmm/article/view/478

Ivermectin for Treatment of COVID-19?

 Ivermectin for Treatment of COVID-19?

 

Hemat Abd El Salam Ahmed Salama (1)

Mohamed Abd El-Rahman Hassan El-Shayeb (2)

Ahmed Nour El-Din Hassan (3,4)

Ghada Essam El-Din Amin (1,5)

Mohamed Farouk Allam (1)

Eman El- Sayed Ahmed (2)

 

1. Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

2. Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

3. Department of Clinical Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

4. Department of Clinical Pharmacology, Faculty of Medicine, Galala University, Cairo, Egypt.

5. Department of Community Medicine, Faculty of Medicine, 6th of October University, Cairo, Egypt.

 

World Journal of Medical Microbiology, 2022, 1, 474

 

DOI: 10.31586/wjmm.2022.474

 

Abstract:

Many attempts have been made to repurpose existing and approved drugs for the treatment of COVID-19 infection. This involves anti-malarial drugs such as hydroxychloroquine and chloroquine, which have been shown to be less successful than initially believed, with a substantial risk of often fatal complications and interactions. This also involves Remdesivir, which has been shown to decrease recovery time significantly in hospitalized patients. However, for patients who are not yet hospitalized, there is no currently accepted treatment. Treating patients before they need to be admitted or even prophylactically could greatly decrease the load on hospitals, protect healthcare workers and reduce the spread of COVID-19. An in-vitro study indicated that Ivermectin was dynamic against COVID-19-infected cell. Ivermectin has antimicrobial, antiviral, and anticancer, immunomodulatory properties. This drug could reduce the viral load in COVID-9 infected patients, with potential effect on disease progression and spread. Therefore, Ivermectin may be a therapeutic choice for treatment of COVID-19, however, there is still a lack of evidence-based studies to support ivermectin treatment of patients with COVID-19.

 

Keywords: Coronavirus, COVID-19, Ivermectin, Treatment, Review.

 

World Journal of Medical Microbiology, 2022, 1, 474

 

https://www.scipublications.com/journal/index.php/wjmm/article/view/474  

Probiotics and Intestinal Microbiome: A Review of Literature

Probiotics and Intestinal Microbiome: A Review of Literature

 

Hadeer Abdel-Aleem Hassan Mohamed Tawfik (1), Mohamed Nazmy Farris (2), Rasha Samir (2,3), Mohamed Nabil Badawy Al Ashram (2), Mina Mikhail Nessim (2), Mohamed Farouk Allam (1)

 

1. Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

2. Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

3. Department of Internal Medicine, Armed Forces College of Medicine, Cairo, Egypt.

 

World Journal of Medical Microbiology, 2022, 1, 479

 

DOI: 10.31586/wjmm.2022.479

 

Abstract:

Probiotics, prebiotics, and synbiotics modify various aspects of local and systemic immune function in multiple experimental models. However, their impact and mechanisms of action are not known across all products or noticed in every population studied, and impacts on in vitro, ex vivo, or other measures of immune function do not necessarily result in an impact on infection and illness in vivo. Studies have discussed that intestinal microbiota has an essential role in enhancing the immune system against viruses. The regulatory impact of the intestinal microbiota on viral infection is connected with local and systemic immune responses and plays a part in congenital and adaptive immune responses. The microbiota composition critically modulates the production of virus-specific CD4 and CD8 T cells and antibody responses following influenza virus infection. The intestinal microbiota has an important role in the stabilizing of immune homeostasis by augmenting the integrity of the barrier functions of the gut mucosa, which is a crucial aspect of systemic immunity. In conclusion, the intestinal microbiota can influence organismal immunity locally and systemically, proximally, and distally. Studying the possible mechanism by which the intestinal microbiota maintains host immunity can provide a clearer understanding of the occurrence and development of diseases.

 

Keywords: Probiotics, Prebiotics, Synbiotics, Intestinal Microbiome, Microbiota, Review.

 

World Journal of Medical Microbiology, 2022, 1, 479

 

https://www.scipublications.com/journal/index.php/wjmm/article/view/479

Nutritional rehabilitation of malnourished children: are nutritional supplements a must?

Nutritional rehabilitation of malnourished children: are nutritional supplements a must?

 

Ehab Khairy Emam (1),  May Fouad Nassar (1),  Mohamed Farouk Allam (2),  Mai Mamdouh Ahmed (3), Heba Essam El-Khouly (1).

 

1. Department of Pediatrics, Faculty of Medicine Ain Shams University, Cairo, Egypt.

2. Department of Family Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

3. Ministry of Health and Population, Cairo, Egypt.

Current Medical Research and Opinion 2022 Oct 13:1-19. 

 

DOI: 10.1080/03007995.2022.2135839

 

Abstract

Objective: Malnutrition threatens children worldwide. The objective of the current study was to highlight the role of nutritional screening, evaluate the effectiveness of nutritional intervention programme, and whether nutritional supplements have surplus benefit. Patients and methods: Screening Tool for the Assessment of Malnutrition in Pediatrics (STAMP) was used to screen 3640 clinically stable 2-5 years old children recruited from the outpatient clinics, Children’s Hospital, Ain Shams University. A total of 100 patients at high risk of malnutrition were recruited. Full nutritional assessment was done and according to the distribution of the calories in the daily meal plan, the patients were randomly divided into two groups each comprised 50 patients. Group A received tailored nutritional dietary rehabilitation plan including dietary supplements, while Group B received only dietary advice. Anthropometric measurements, laboratory tests, as well as STAMP scoring were reassessed after the nutritional rehabilitation Programs. Results: Nutritional screening revealed that 5.14% were at high risk of malnutrition. Both studied groups showed significant improvement in caloric intake and all anthropometric measurements upon nutritional rehabilitation, except for the height z scores. Patients who received nutritional supplements showed significantly better changes regarding weight, BMI, caloric intake, and hemoglobin. Regarding STAMP categories during follow up, Group A had only 6% of the patients still in the high-risk category and 76% were at low risk compared to 14% high risk and only 54% were at low risk in Group B. Conclusion: Nutritional screening in pediatric outpatient facilities can lead to implementing prompt nutritional rehabilitation which can reflect on their overall health. Tailored nutritional plan can accomplish good response in terms of improvement of caloric intake, anthropometric measurements and laboratory parameters. Adding a nutritional supplement to the dietary plan during nutritional rehabilitation isn’t a must but it ensures superior goal achievement.

 

Keywords: Ain Shams University; Intervention Study; Malnutrition; Nutritional rehabilitation; Nutritional supplements; STAMP.

 

Current Medical Research and Opinion 2022 Oct 13:1-19. 

 

https://www.tandfonline.com/doi/full/10.1080/03007995.2022.2135839